Central Nervous System Agents in Medicinal Chemistry
Title:Meet Our Associate Board Member
Volume: 20 Issue: 1
Author(s): Majid Asadi-Shekaari
Affiliation:
Export Options
About this article
Cite this article as:
Asadi-Shekaari Majid, Meet Our Associate Board Member, Central Nervous System Agents in Medicinal Chemistry 2020; 20 (1) . https://dx.doi.org/10.2174/187152492001200303164412
DOI https://dx.doi.org/10.2174/187152492001200303164412 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
15
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Importance of Nicotinic Acetylcholine Receptors in Schizophrenia, Bipolar Disorder and Tourettes Syndrome
Current Drug Targets - CNS & Neurological Disorders Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy
Current Drug Safety Preface (Nicholas D. P. Cosford)
Current Drug Targets - CNS & Neurological Disorders Caspase-3 Short Hairpin RNAs: A Potential Therapeutic Agent in Neurodegeneration of Aluminum-Exposed Animal Model
Current Alzheimer Research Matrix Metalloproteinase Dependent Cleavage of Cell Adhesion Molecules in the Pathogenesis of CNS Dysfunction with HIV and Methamphetamine
Current HIV Research The FKBP51-Glucocorticoid Receptor Balance in Stress-Related Mental Disorders
Current Molecular Pharmacology MicroRNAs as Potential Therapeutic Agents in the Treatment of Myocardial Infarction
Current Vascular Pharmacology Pathologically-Activated Therapeutics for Neuroprotection: Mechanism of NMDA Receptor Block by Memantine and S-Nitrosylation
Current Drug Targets Copper Status Abnormalities and How to Measure Them in Neurodegenerative Disorders
Recent Patents on CNS Drug Discovery (Discontinued) The Dendritic Cell-T Cell Synapse as a Determinant of Autoimmune Pathogenesis
Current Pharmaceutical Design Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) and its Lipid Ligands
Current Medicinal Chemistry Chemoprevention of Colorectal Cancer: Progress or Pipedream?
Current Cancer Therapy Reviews White Matter Damage Along the Uncinate Fasciculus Contributes to Cognitive Decline in AD and DLB
Current Alzheimer Research Drugs from the Sea: Conopeptides as Potential Therapeutics
Current Medicinal Chemistry Gene Therapy Strategies to Prevent Autoimmune Disorders
Current Gene Therapy Review of Recent Clinical Developments and Patents for the Treatment of Autoimmune and Inflammatory Diseases by Mesenchymal Stromal Cells
Recent Patents on Regenerative Medicine Functional and Structural Neural Changes in Obsessive-compulsive Disorder after Pharmacotherapy
Current Neuropharmacology Resilience to Alzheimer's Disease: The Role of Physical Activity
Current Alzheimer Research Identifying Changes in the Synaptic Proteome of Cirrhotic Alcoholic Superior Frontal Gyrus
Current Neuropharmacology Protective Role of <i>Morus nigra</i> Leaf Extracts against Murine Infection with <i>Eimeria papillata</i>
Combinatorial Chemistry & High Throughput Screening